Giuseppe Aminzade, head of regulatory life sciences in BonelliErede’s Healthcare & Life Sciences Focus Team, reflects on ...
Over the past decade, neurodegenerative research and development has responsibly answered a foundational question: can we ...
Hosted on MSN
Over the past decade, early-stage drug innovation has shifted toward China, researchers find
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Development teams that benefit most from high-resolution additive manufacturing are using it to ask better questions earlier ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today its decision to proceed with Phase III development of prasinezumab, ...
A new federally funded research effort in Rochester is aiming to tackle one of the biggest gaps in treating age-related ...
WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results